Pulse Biosciences (PLSE) Cash from Financing (Quarterly): 52.10M

Pulse Biosciences, Inc. (PLSE)

44.43 -1.16 (-2.54%) USD | NASDAQ | Oct 16, 16:00

44.39 -0.04 (-0.09%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2016. Start Trial.

Date	Value
June 30, 2026	52.10M
March 31, 2026	2.212M
December 31, 2025	0.381M
September 30, 2025	1.966M
June 30, 2025	0.00
March 31, 2025	14.81M
December 31, 2024	48.20M
September 30, 2024	61.90M
June 30, 2024	-0.265M
March 31, 2024	0.305M
December 31, 2023	0.798M
September 30, 2023	2.155M
June 30, 2023	13.87M
March 31, 2023	-0.432M
December 31, 2022	-0.017M
September 30, 2022	65.06M
June 30, 2022	14.96M
March 31, 2022	-0.065M
December 31, 2021	-0.549M
September 30, 2021	8.072M
June 30, 2021	4.004M

Date	Value
March 31, 2021	51.16M
December 31, 2020	0.436M
September 30, 2020	0.426M
June 30, 2020	29.76M
March 31, 2020	0.264M
December 31, 2019	0.00
September 30, 2019	0.201M
June 30, 2019	-0.613M
March 31, 2019	0.494M
December 31, 2018	44.86M
September 30, 2018	0.398M
June 30, 2018	-0.063M
March 31, 2018	0.30M
December 31, 2017	0.188M
September 30, 2017	30.01M
June 30, 2017	0.215M
March 31, 2017	4.971M
December 31, 2016	0.00
September 30, 2016	0.00
June 30, 2016	20.92M
March 31, 2016	0.00

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks